Search

Search Constraints

You searched for: Author/Creator Shimazaki, Chihiro

Search Results

2. Clinical manifestation and prognostic factors of 32 Japanese patients with autoimmune disease-associated diffuse large B-cell lymphoma. Issue 3 (March 2015)

3. Hematopoietic progenitor cell mobilization using low‐dose cyclophosphamide and granulocyte colony‐stimulating factor for multiple myeloma. Issue 5 (27th June 2013)

4. Isatuximab monotherapy in relapsed/refractory multiple myeloma: A Japanese, multicenter, phase 1/2, safety and efficacy study. Issue 12 (15th October 2020)

5. Monitoring treatment response to tafamidis by serial native T1 and extracellular volume in transthyretin amyloid cardiomyopathy. (27th November 2018)

6. Monocyte or white blood cell counts and β2 microglobulin predict the durable efficacy of daratumumab with lenalidomide. (December 2022)

7. Outcomes of ixazomib/lenalidomide/dexamethasone for multiple myeloma: A multicenter retrospective analysis. (31st January 2021)

8. Patients assigned to VGPR, PR, and SD in the IMWG response category are composed of heterogeneous population when assessed by the heavy/light chain assay. Issue 3 (26th April 2019)

9. Plateau is a prognostic factor of lenalidomide therapy for previously treated multiple myeloma. Issue 3 (28th March 2021)

10. Pretreatment serum level of interleukin-6 predicts carfilzomib-induced hypertension in relapsed/refractory multiple myeloma. Issue 7 (7th June 2022)